Skip to content

FEKA

Femoral embolism during cemented total knee arthroplasty, a feasibility study - Femoral embolism during cemented total knee arthroplasty, a pilot study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON57978
Enrollment
30
Registered
2025-05-27
Start date
2026-03-12
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone cement implantation syndrome, Fat embolism Fat embolism

Interventions

The surgical and anesthesiologic procedures are carried out as usual, with no changes implemented. What is added to the procedure is performing the external femoral ultrasound:To minimize intraoperati
ensuring it does not interfere with the sterile surgical field. As such, there is no increased risk of infection due to the ultrasound. Additionally, patients will not need to be repositioned or undre
External ultrasound assessments wil

Sponsors

Spaarne Gasthuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients warranting cemented total knee arthroplastyMinimum age of 18 yearsWritten and signed informed consent

Exclusion criteria

Exclusion criteria: Obesity (BMI>35 kg/m2)

Design outcomes

Primary

MeasureTime frame
The presence of embolic events and grading of the embolic events. Femoral embolic events will be monitored and recorded using external femoral ultrasound from 5 minutes before cementation until the end of the surgery. The observation of maximum grade of embolic events will be classified according to an established criterion with the following echogenic patterns:18Grade 0: no emboliGrade 1: a few fine emboliGrade 2: a cascade of fine emboli or embolic masses less than 5 mm in diameter and the right atrium opacified with echogenic materialsGrade 3: fine emboli mixed with large embolic masses greater than 5 mm in diameter or serpentine emboli

Secondary

MeasureTime frame
The secondary study endpoint will be the occurrence of overall BCIS:Yes:SpO2 <94% after cementation up until skin closure, AND/ORFall in SBP fall > 20% after cementation up until skin closureNo.Tertiary study outcome:  The severity of BCIS according to the following classification:Grade 1: moderate hypoxia (SpO2 <94%) or hypotension (fall in SBP > 20% and < 40%), or both Grade 2: severe hypoxia (SpO2 <88%) or hypotension (fall in SBP > 40%), or both, or unexpected loss of consciousnessGrade 3: cardiovascular collapse requiring CPRAll parameters will be recorded at 2-minute intervals. Following cementation, measurements will be taken every minute for a duration of 10 minutes. The aforementioned parameters will be assessed non-invasively using an automatic upper-arm blood pressure monitor and a pulse oximeter.Determinant: Femoral embolic events will be monitored and recorded using external femoral ultrasound from 5 minutes before cementation until the end of the surgery. The observation of maximum grade of embolic events will be classified according to an established criterion with the echogenic patterns as described in 5.1.1. 

Countries

Netherlands

Contacts

Public ContactKE Brokke

Spaarne Gasthuis

kbrokke@spaarnegasthuis.nl0631950716

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Aug 10, 2026